Jeremy John Erasmus, M.D.

Peer-Reviewed Articles

1. Fong KM, Rosenthal A, Giroux DJ, Nishimura KK, Erasmus J, Lievens Y, Marino M, Marom EM, Putora PM, Singh N, Suárez F, Rami-Porta R, Detterbeck F, Eberhardt WEE, Asamura H, Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Members of the Advisory Boards, and Participating Institutions of the Lung Cancer Domain. The IASLC lung cancer staging project: Proposals for the revision of the M descriptors in the forthcoming 9th edition of the "TNM Classification of Lung Cancer". J Thorac Oncol 19(5):786-802, 2024. e-Pub 2024. PMID: 38320664.
2. Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. Stereotactic ablative radiation therapy for sarcoma lung metastases: Indications for treatment and guidance for patient selection. Int J Radiat Oncol Biol Phys 118(4):971-978, 2024. e-Pub 2023. PMID: 37914142.
3. Gill RR, Nowak AK, Giroux DJ, Eisele M, Rosenthal A, Kindler H, Wolf A, Ripley RT, Billé A, Rice D, Opitz I, Rimner A, dePerrot M, Pass HI, Rusch VW, IASLC Staging and Prognostic Factors Committee (Erasmus J), Advisory Boards and Participating Institution. The IASLC mesothelioma staging project: Proposals for revisions of the 'T' descriptors in the forthcoming 9th edition of the "TNM Classification for Pleural Mesothelioma". J Thorac Oncol. e-Pub 2024. PMID: 38521202.
4. Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WL. Gastric extent of tumor predicts peritoneal metastasis in Siewert II adenocarcinoma. Ann Thorac Surg 117(2):320-326, 2024. e-Pub 2023. PMID: 37080372.
5. Katz SI, Straus CM, Roshkovan L, Blyth KG, Frauenfelder T, Gill RR, Lalezari F, Erasmus J, Nowak AK, Gerbaudo VH, Francis RJ, Armato SG. Considerations for imaging of malignant pleural mesothelioma: A consensus statement from the International Mesothelioma Interest Group (IMIG). J Thorac Oncol 18(3):278-298, 2023. e-Pub 2022. PMID: 36549385.
6. Betancourt Cuellar SL, Benveniste MF, Truong M, Nguyen QN, Atiyah A, Hofstetter WL, Erasmus JJ. Liver injury in patients with distal esophageal carcinoma after precision radiation therapy: Systematic review of FDG-PET/CT patterns. Am J Clin Oncol 46(1):25-30, 2023. e-Pub 2022. PMID: 36562692.
7. Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt Cuellar SL. Clinical significance of FDG-PET/CT avid hilar lymph nodes in esophageal carcinoma patients. Ann Thorac Surg 114(4):1183-1188, 2022. e-Pub 2021. PMID: 34634240.
8. Ruffini E, Rami-Porta R, Huang J, Ahmad U, Appel S, Bille A, Boubia S, Brambilla C, Cangir AK, Cilento V, Detterbeck F, Falkson C, Fang W, Filosso PL, Giaccone G, Girard N, Guerrera F, Infante M, Kim DK, Lucchi M, Marino M, Marom EM, Nicholson AG, Okumura M, Rimner A, Simone CB, Asamura H, IASLC Staging and Prognostic Factors Committee and of the Advisory Boards (Erasmus J). The international association for the study of lung cancer thymic epithelial tumor staging project: Unresolved issues to be addressed for the next ninth edition of the TNM classification of malignant tumors. J Thorac Oncol 17(6):838-851, 2022. e-Pub 2022. PMID: 35321838.
9. Strange CD, Shroff GS, Truong MT, Nguyen QN, Vlahos I, Erasmus JJ. Imaging of the post-radiation chest in lung cancer. Clin Radiol 77(1):19-30, 2022. e-Pub 2021. PMID: 34090709.
10. Vlahos I, Erasmus JJ, Truong MT. Special issue on imaging the post cancer-treatment chest: Heralding a new definition of an "expert thoracic imager"?. Clin Radiol 77(1):3-5, 2022. e-Pub 2021. PMID: 34876243.
11. Betancourt-Cuellar SL, Palacio DP, Benveniste MFK, Mawlawi Y, Erasmus JJ. Pitfalls and pearls in esophageal carcinoma. Semin Ultrasound CT MR 42(6):535-541, 2021. e-Pub 2021. PMID: 34895609.
12. Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. Radiother Oncol 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
13. Skinner H, Hu C, Tsakiridis T, Santana-Davila R, Lu B, Erasmus JJ, Doemer AJ, Videtic GMM, Coster J, Yang AX, Lee RY, Werner-Wasik M, Schaner PE, McCormack SE, Esparaz BT, McGarry RC, Bazan J, Struve T, Paulus R, Bradley JD. Addition of metformin to concurrent chemoradiation in patients with locally advanced non-small cell lung cancer: The NRG-LU001 phase 2 randomized clinical trial. JAMA Oncol 7(9):1324-1332, 2021. e-Pub 2021. PMID: 34323922.
14. Hamill JJ, Meier JG, Betancourt Cuellar SL, Sabloff B, Erasmus JJ, Mawlawi O. Improved alignment of PET and CT images in whole-body PET/CT in cases of respiratory motion during CT. J Nucl Med 61(9):1376-1380, 2020. e-Pub 2020. PMID: 32005768.
15. Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, Liao Z, Erasmus JJ, Nguyen QN. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 42(8):1939-1953, 2020. e-Pub 2020. PMID: 32129548.
16. Lowenstein LM, Godoy MCB, Erasmus JJ, Zirari Z, Bennett A, Leal VB, Housten AJ, Volk RJ. Implementing decision coaching for lung cancer screening in the low-dose computed tomography setting. JCO Oncol Pract 16(8):JOP1900453, 2020. e-Pub 2020. PMID: 32208092.
17. Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Ferreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, Kris M, Jain D, Kim YT, Lopez-Rios F, Lu S, Mitsudomi T, Moreira A, Motoi N, Nicholson AG, Oliveira R, Papotti M, Pastorino U, Paz-Ares L, Pelosi G, Poleri C, Provencio M, Roden AC, Scagliotti G, Swisher SG, Thunnissen E, Tsao MS, Vansteenkiste J, Weder W, Yatabe Y. IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens following neoadjuvant therapy. J Thorac Oncol 15(5):709-740, 2020. e-Pub 2020. PMID: 32004713.
18. Pasalic D, Lu Y, Betancourt-Cuellar SL, Taku N, Mesko SM, Bagley AF, Chance WW, Allen PK, Tang C, Antonoff MB, Balter PA, Mehran RJ, Welsh JW, Liao Z, Gomez D, Erasmus JJ, Nguyen QN. Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure. Radiother Oncol 145:178-185, 2020. e-Pub 2020. PMID: 32044530.
19. Meier JG, Erasmus JJ, Gladish GW, Peterson CB, Diab RH, Mawlawi OR. Characterization of continuous bed motion effects on patient breathing and respiratory motion correction in PET/CT imaging. J Appl Clin Med Phys 21(1):158-165, 2020. e-Pub 2019. PMID: 31816183.
20. Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB. Surveillance after treatment of non-small-cell lung cancer: A call for multidisciplinary standardization. Innovations (Phila) 15(1):1556984519886281, 2020. e-Pub 2019. PMID: 31875755.
21. Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. Results of a phase 1/2 trial of chemoradiotherapy with simultaneous integrated boost of radiotherapy dose in unresectable locally advanced esophageal cancer. JAMA Oncol 5(11):1597-1604, 2019. e-Pub 2019. PMID: 31529018.
22. Nelson DB, Tayob N, Nguyen QN, Erasmus J, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB, Mehran RJ. Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases. J Thorac Cardiovasc Surg 158(4):1234-1241.e16, 2019. e-Pub 2019. PMID: 31395367.
23. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal nodal involvement after neoadjuvant chemoradiation for siewert II/III adenocarcinoma. Ann Thorac Surg 108(3):845-851, 2019. e-Pub 2019. PMID: 31102632.
24. Menon H, Chen D, Ramapriyan R, Verma V, Barsoumian HB, Cushman TR, Younes AI, Cortez MA, Erasmus JJ, de Groot P, Carter BW, Hong DS, Glitza IC, Ferrarotto R, Altan M, Diab A, Chun SG, Heymach JV, Tang C, Nguyen QN, Welsh JW. Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer 7(1):237, 2019. e-Pub 2019. PMID: 31484556.
25. Sheshadri A, Godoy M, Erasmus JJ, Gruschkus S, Hasan A, Evans SE, Barreda-Garcia J, Chemaly RF, Dickey B, Ost D. Progression of the radiologic severity index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia. BMJ Open Respir Res 6(1):e000471, 2019. e-Pub 2019. PMID: 31921429.
26. Kim MP, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Occult stage IIIA-N2 patients have excellent overall survival with initial surgery. J Thorac Dis 10(12):6670-6676, 2018. PMID: 30746212.
27. Yu W, Tang C, Hobbs BP, Li X, Koay EJ, Wistuba II, Sepesi B, Behrens C, Rodriguez Canales J, Parra Cuentas ER, Erasmus JJ, Court LE, Chang JY. Development and validation of a predictive radiomics model for clinical outcomes in stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 102(4):1090-1097, 2018. e-Pub 2017. PMID: 29246722.
28. Meier JG, Wu CC, Betancourt Cuellar SL, Truong MT, Erasmus JR, Einstein S, Mawlawi O. Evaluation of a novel elastic respiratory motion correction algorithm on quantification and image quality in abdomino-thoracic PET/CT. J Nucl Med 60(2):279-284, 2018. PMID: 30115689.
29. Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY. Association of long-term outcomes and survival with multidisciplinary salvage treatment for local and regional recurrence after stereotactic ablative radiotherapy for early-stage lung cancer. JAMA Netw Open 1(4):e181390, 2018. e-Pub 2018. PMID: 30646121.
30. Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV. STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-Mutant lung adenocarcinoma. Cancer Discov 8(7):822-835, 2018. e-Pub 2018. PMID: 29773717.
31. Godoy MCB, White CS, Erasmus JJ, Wu CC, Truong MT, Munden RF, Chiles C. Extrapulmonary neoplasms in lung cancer screening. Transl Lung Cancer Res 7(3):368-375, 2018. PMID: 30050774.
32. Giroux DJ, Van Schil P, Asamura H, Rami-Porta R, Chansky K, Crowley JJ, Rusch VW, Kernstine K, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee (Erasmus JJ). The IASLC lung cancer staging project: A renewed call to participation. J Thorac Oncol 13(6):801-809, 2018. e-Pub 2018. PMID: 29476906.
33. Erasmus JJ, Truong MT. Imaging of lung cancer: Update on screening, staging, and therapy. Radiol Clin North Am 56(3):xv-xvi, 2018. PMID: 29622081.
34. de Groot PM, Shroff GS, Ahrar J, Sabloff BS, Gladish GM, Moran C, Gupta S, Gladish GW, Chang JY, Erasmus JJ. Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant. Adv Radiat Oncol 3(2):139-145, 2018. e-Pub 2017. PMID: 29904738.
35. Carter BW, Lichtenberger JP, Benveniste MK, de Groot PM, Wu CC, Erasmus JJ, Truong MT. Revisions to the TNM staging of lung cancer: Rationale, significance, and clinical application. Radiographics 38(2):374-391, 2018. PMID: 29528831.
36. Sheshadri A, Shah DP, Godoy M, Erasmus JJ, Song J, Li L, Evans SE, Chemaly RF, Dickey BF, Ost DE. Progression of the radiologic severity index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections. PLoS One 13(5):e0197418, 2018. e-Pub 2018. PMID: 29771962.
37. Shimodaira Y, Slack RS, Harada K, Bhutani MS, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JA. Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma. Oncotarget 8(45):79356-79365, 2017. e-Pub 2017. PMID: 29108314.
38. Erasmus JJ, Truong MT. Paradigm shift in lung cancer therapy: Imaging and clinical implications. J Thorac Imaging 32(5):275, 2017. PMID: 28832413.
39. Carter BW, Erasmus JJ, Truong MT, Shepard JO, Hofstetter W, Clarke R, Munden RF, Steele JR. Quality and value of subspecialty reinterpretation of thoracic CT scans of patients referred to a tertiary cancer center. J Am Coll Radiol 14(8):1109-1118, 2017. e-Pub 2017. PMID: 28434844.
40. Mizrak Kaya D, Dong X, Nogueras-González GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients. Med Oncol 34(8):135, 2017. e-Pub 2017. PMID: 28685276.
41. Godoy MCB, Pereira HAC, Carter BW, Wu CC, Erasmus JJ. Incidental findings in lung cancer screening: Which ones are relevant?. Semin Roentgenol 52(3):156-160, 2017. e-Pub 2017. PMID: 28734397.
42. Betancourt Cuellar SL, Sabloff B, Carter BW, Benveniste MF, Correa AM, Maru DM, Ajani JA, Erasmus JJ, Hofstetter WL. Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?. Eur J Radiol 88(3):56-60, 2017. e-Pub 2017. PMID: 28189209.
43. Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. Local control and toxicity of a simultaneous integrated boost for dose escalation in locally advanced esophageal cancer: Interim results from a prospective phase I/II trial. J Thorac Oncol 12(2):375-382, 2017. e-Pub 2016. PMID: 27794500.
44. Rusch VW, Chansky K, Kindler HL, Nowak AK, Pass HI, Rice DC, Shemanski L, Galateau-Sallé F, McCaughan BC, Nakano T, Ruffini E, van Meerbeeck JP, Yoshimura M; IASLC Staging and Prognostic Factors Committee, advisory boards, and participating institutions (Erasmus JJ). The IASLC mesothelioma staging project: Proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma. J Thorac Oncol 11(12):2112-2119, 2016. e-Pub 2016. PMID: 27687962.
45. Pass H, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, Asamura H, Waller D, Edwards J, Weder W, Hoffmann H, van Meerbeeck JP, Nowak A, Rusch VW, IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions (Erasmus JJ). The IASLC mesothelioma staging project: Improving staging of a rare disease through international participation. J Thorac Oncol 11(12):2082-2088, 2016. e-Pub 2016. PMID: 27670823.
46. Rusch VW, Gill R, Mitchell A, Naidich D, Rice DC, Pass HI, Kindler HL, De Perrot M, Friedberg J, Malignant Mesothelioma Volumetric CT Study Group (Erasmus JJ). A multicenter study of volumetric computed tomography for staging malignant pleural mesothelioma. Ann Thorac Surg 102(4):1059-66, 2016. e-Pub 2016. PMID: 27596916.
47. Detterbeck FC, Chansky K, Groome P, Bolejack V, Crowley J, Shemanski L, Kennedy C, Krasnik M, Peake M, Rami-Porta R, IASLC Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions (Erasmus JJ). The IASLC lung cancer staging project: Methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (eighth) edition of the TNM classification of lung cancer. J Thorac Oncol 11(9):1433-46, 2016. e-Pub 2016. PMID: 27448762.
48. Gill RR, Naidich DP, Mitchell A, Ginsberg M, Erasmus J, Armato SG, Straus C, Katz S, Patios D, Richards WG, Rusch VW, Malignant Mesothelioma Volumetric CT Study Group. North American multicenter volumetric CT study for clinical staging of malignant pleural mesothelioma: Feasibility and logistics of setting up a quantitative imaging study. J Thorac Oncol 11(8):1335-1344, 2016. e-Pub 2016. PMID: 27180318.
49. Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, Goo JM, MacMahon H, Naidich D, Nicholson AG, Powell CA, Prokop M, Rami-Porta R, Rusch V, van Schil P, Yatabe Y, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board Members (Erasmus JJ). The IASLC lung cancer staging project: Proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 11(8):1204-23, 2016. e-Pub 2016. PMID: 27107787.
50. Cho J, Ibbott GS, Kerr MD, Amos RA, Stingo FC, Marom EM, Truong MT, Palacio DM, Betancourt SL, Erasmus JJ, DeGroot PM, Carter BW, Gladish GW, Sabloff BS, Benveniste MF, Godoy MC, Patil S, Sorensen J, Mawlawi OR. Characterizing proton-activated materials to develop PET-mediated proton range verification markers. Phys Med Biol 61(11):N291-310, 2016. e-Pub 2016. PMID: 27203621.
51. Detterbeck FC, Bolejack V, Arenberg DA, Crowley J, Donington JS, Franklin WA, Girard N, Marom EM, Mazzone PJ, Nicholson AG, Rusch VW, Tanoue LT, Travis WD, Asamura H, Rami-Porta R, IASLC Staging and Prognostic Factors Committee, Advisory Boards, Multiple Pulmonary Sites Workgroup and Participating Institutions, IASLC Staging and Prognostic Factors Committee Advisory Boards Multiple Pulmonary Sites Workgroup and Participating Institutions (Erasmus JJ). The IASLC lung cancer staging project: Background data and proposals for the classification of lung cancer with separate tumor nodules in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 11(5):681-692, 2016. e-Pub 2016. PMID: 26940530.
52. Detterbeck FC, Nicholson AG, Franklin WA, Marom EM, Travis WD, Girard N, Arenberg DA, Bolejack V, Donington JS, Mazzone PJ, Tanoue LT, Rusch VW, Crowley J, Asamura H, Rami-Porta R, IASLC Staging and Prognostic Factors Committee, Advisory Boards, Multiple Pulmonary Sites Workgroup and Participating Institutions, IASLC Staging and Prognostic Factors Committee Advisory Boards Multiple Pulmonary Sites Workgroup and Participating Institutions (Erasmus JJ). The IASLC lung cancer staging project: Summary of proposals for revisions of the classification of lung cancers with multiple pulmonary sites of involvement in the forthcoming eighth edition of the TNM classification. J Thorac Oncol 11(5):639-650, 2016. e-Pub 2016. PMID: 26940528.
53. Detterbeck FC, Marom EM, Arenberg DA, Franklin WA, Nicholson AG, Travis WD, Girard N, Mazzone PJ, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R, IASLC Staging and Prognostic Factors Committee, Advisory Boards and the Multiple Pulmonary Sites Workgroup, IASLC Staging and Prognostic Factors Committee Advisory Boards and the Multiple Pulmonary Sites Workgroup (Erasmus JJ). The IASLC lung cancer staging project: Background data and proposals for the application of TNM staging rules to lung cancer presenting as multiple nodules with ground glass or lepidic features or a pneumonic-type of involvement in the forthcoming eighth edition of the TNM classification. J Thorac Oncol 11(5):666-680, 2016. e-Pub 2016. PMID: 26940527.
54. Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R, IASLC Staging and Prognostic Factors Committee, Advisory Boards and the Multiple Pulmonary Sites Workgroup, IASLC Staging and Prognostic Factors Committee Advisory Boards and the Multiple Pulmonary Sites Workgroup (Erasmus JJ). The IASLC lung cancer staging project: Background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 11(5):651-665, 2016. e-Pub 2016. PMID: 26944304.
55. Nicholson AG, Chansky K, Crowley J, Beyruti R, Kubota K, Turrisi A, Eberhardt WE, van Meerbeeck J, Rami-Porta R, Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions, Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. (Erasmus JJ). The international association for the study of lung cancer lung cancer staging project: Proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 11(3):300-311, 2016. e-Pub 2015. PMID: 26723244.
56. Glastonbury CM, Bhosale PR, Choyke PL, D'Orsi CJ, Erasmus JJ, Gill RR, Mukherji SK, Panicek DM, Schwartz LH, Subramaniam RM, Sullivan DC. Do radiologists have stage fright? Tumor staging and how we can add value to the care of the patients with cancer. Radiology 278(1):11-12, 2016. PMID: 26690989.
57. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions (Erasmus JJ). The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11(1):39-51, 2016. PMID: 26762738.
58. Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, Watanabe H, Wu YL, Zielinski M, Ball D, Rami-Porta R; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions. (Erasmus JJ). The international association for the study of lung cancer lung cancer staging project: Proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol 10(12):1675-84, 2015. PMID: 26709477.
59. Eberhardt WE, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A 3rd, Goldstraw P, Rami-Porta R; International Association for Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions (Erasmus JJ). The IASLC lung cancer staging project: Proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 10(11):1515-22, 2015. PMID: 26536193.
60. Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, Wu YL; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions (Erasmus JJ). The IASLC lung cancer staging project: Proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 10(7):990-1003, 2015. PMID: 26134221.
61. Recondo G, Busaidy N, Erasmus J, Williams MD, Johnson FM. Spindle epithelial tumor with thymus-like differentiation (SETTLE): A case report and comprehensive review of the literature and treatment options. Head Neck 37(5):746-54, 2015. e-Pub 2014. PMID: 24677409.
62. Gomez DR, Liao KP, Swisher SG, Blumenschein GR, Erasmus JJ, Buchholz TA, Giordano SH, Smith BD. Time to treatment as a quality metric in lung cancer: staging studies, time to treatment, and patient survival. Radiother Oncol 115(2):257-63, 2015. e-Pub 2015. PMID: 26013292.
63. Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Limitations of 18F-2-deoxy-d-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management. Ann Thorac Surg 99(2):414-20, 2015. e-Pub 2014. PMID: 25497068.
64. Godoy MC, Saldana DA, Rao PP, Vlahos I, Naidich DP, Benveniste MF, Erasmus JJ, Marom EM, Ost D. Multidetector CT evaluation of airway stents: What the radiologist should know. Radiographics 34(7):1793-806, 2014. PMID: 25384279.
65. Gold KA, Lee JJ, Harun N, Tang X, Price J, Kawedia JD, Tran HT, Erasmus JJ, Blumenschein GR, William WN, Wistuba II, Johnson FM. A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer. Oncologist 19(10):1040-1, 2014. e-Pub 2014. PMID: 25170013.
66. Truong MT, Ko JP, Rossi SE, Rossi I, Viswanathan C, Bruzzi JF, Marom EM, Erasmus JJ. Update in the evaluation of the solitary pulmonary nodule. Radiographics 34(6):1658-79, 2014. PMID: 25310422.
67. Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: Does FDG-PET/CT have a role?. J Thorac Oncol 9(8):1202-1206, 2014. PMID: 25157774.
68. Gomez DR, Gladish GW, Wei X, Kotamarti KR, Allen PK, Cox JD, O'Reilly MS, Erasmus JJ, Fossella FV, Komaki R. Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy. Am J Clin Oncol 37(1):77-80, 2014. PMID: 23111360.
69. Blumenschein GR, Saintigny P, Liu S, Kim ES, Tsao AS, Herbst RS, Alden C, Lee JJ, Tang X, Stewart DJ, Kies MS, Fossella FV, Tran HT, Mao L, Hicks ME, Erasmus J, Gupta S, Girard L, Peyton M, Diao L, Wang J, Davis SE, Minna JD, Wistuba I, Hong WK, Heymach JV, Lippman SM. Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE (biomarker-integrated approaches of targeted therapy for lung cancer elimination) trial. Clin Cancer Res 19(24):6967-75, 2013. e-Pub 2013. PMID: 24166906.
70. Detterbeck FC, Asamura H, Crowley J, Falkson C, Giaccone G, Giroux D, Huang J, Kim J, Kondo K, Lucchi M, Marino M, Marom EM, Nicholson A, Okumura M, Ruffini E, van Schil P, Stratton K, Staging and Prognostic Factors Committee, Members of the Advisory Boards, Participating Institutions of the Thymic Domain (Erasmus JJ). The IASLC/ITMIG thymic malignancies staging project: Development of a stage classification for thymic malignancies. J Thorac Oncol 8(12):1467-73, 2013. PMID: 24389429.
71. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-9, 2013. e-Pub 2013. PMID: 23994746.
72. Evans JD, Gomez DR, Chang JY, Gladish GW, Erasmus JJ, Rebueno N, Banchs J, Komaki R, Welsh JW. Cardiac (18)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol 109(1):82-8, 2013. e-Pub 2013. PMID: 24016676.
73. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J, National Lung Screening Trial Research Team (Erasmus JJ). Results of the two incidence screenings in the national lung screening trial. N Engl J Med 369(10):920-31, 2013. PMID: 24004119.
74. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, University of Texas MD Anderson Esophageal Cancer Group. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-7, 2013. PMID: 24022442.
75. Tam AL, Kim ES, Lee JJ, Ensor JE, Hicks ME, Tang X, Blumenschein GR, Alden CM, Erasmus JJ, Tsao A, Lippman SM, Hong WK, Wistuba II, Gupta S. Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. J Thorac Oncol 8(4):436-42, 2013. e-Pub 2013. PMID: 23442309.
76. William WN, Pataer A, Kalhor N, Correa AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, Gold KA, Papadimitrakopoulou V, Swisher SG, Erasmus JJ, University of Texas M.D. Anderson Lung Cancer Collaborative Research Group. Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy. J Thorac Oncol 8(2):222-8, 2013. e-Pub 2013. PMID: 23287849.
77. Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 2012. e-Pub 2012. PMID: 22831985.
78. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32; discussion 1132-3, 2012. e-Pub 2012. PMID: 22921233.
79. Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG, University of Texas M. D. Anderson Lung Cancer Collaborative Research Group. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol 7(5):825-32, 2012. e-Pub 2012. PMID: 22481232.
80. Amini A, Yang J, Williamson R, McBurney ML, Erasmus J, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J, Dong L, Welsh J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys 82(3):e391-8, 2012. PMID: 22284035.
81. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-113. e-Pub 2012. PMID: 22328056.
82. Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, Nunez MI, Wistuba II, Erasmus JJ, Hicks ME, Grimm EA, Reuben JM, Baladandayuthapani V, Templeton NS, McMannis JD, Roth JA. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One 7(4):e34833, 2012. e-Pub 2012. PMID: 22558101.
83. Xiang ZL, Erasmus J, Komaki R, Cox JD, Chang JY. FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy. Radiat Oncol 7(1):144, 2012. e-Pub 2012. PMID: 22929048.
84. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-304, 2012. e-Pub 2012. PMID: 22964903.
85. Rice D, Rusch V, Pass H, Asamura H, Nakano T, Edwards J, Giroux DJ, Hasegawa S, Kernstine KH, Waller D, Rami-Porta R, International Association for the Study of Lung Cancer International Staging Committee (Erasmus JJ) and the International Mesothelioma Interest Group. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: A consensus report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. J Thorac Oncol 6(8):1304-12, 2011. PMID: 21847060.
86. National Lung Screening Trial Research Team (Erasmus JJ), Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395-409, 2011. e-Pub 2011. PMID: 21714641.
87. Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR, Tsao A, Stewart DJ, Hicks ME, Erasmus J, Gupta S, Alden CM, Liu S, Tang X, Khuri FR, Tran HT, Johnson BE, Heymach JV, Mao L, Fossella F, Kies MS, Papadimitrakopoulou V, Davis SE, Lippman SM, Hong WK. The BATTLE trial: Personalizing therapy for lung cancer. Cancer Discov 1(1):44-53, 2011. e-Pub 2011. PMID: 22586319.
88. National Lung Screening Trial Research Team (Erasmus JJ), Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ. The national lung screening trial: Overview and study design. Radiology 258(1):243-253, 2011. e-Pub 2010. PMID: 21045183.
89. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, MD Anderson Esophageal Cancer Group (Erasmus JJ), University of Rochester School of Medicine and Dentistry Foregut Group. Endoscopic esophageal tumor length; a prognostic factor for patients with esophageal cancer. Cancer 117(1):63-69, 2011. e-Pub 2010. PMID: 20803613.
90. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-81, 2011. PMID: 21623235.
91. Munden RF, Erasmus JJ, Wahba H, Fineberg NS. Follow-up of small (4 mm or less) incidentally detected nodules by computed tomography in oncology patients: A retrospective review. J Thorac Oncol 5(12):1958-1962, 2010. PMID: 20978449.
92. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group (Erasmus JJ) and the University of Rochester School of Medicine and Dentistry Foregut Group. A clinical nomogram predicting pathologic lymph-node involvement in esophageal cancer patients. Ann Surg 252(4):611-7, 2010. PMID: 20881767.
93. Johnson FM, Bekele BN, Feng L, Wistuba I, Tang XM, Tran HT, Erasmus JJ, Hwang LL, Takebe N, Blumenschein GR, Lippman SM, Stewart DJ. Phase II study of dasatinib in patients with advanced non-small cell lung cancer. J Clin Oncol 28(30):4609-4615, 2010. e-Pub 2010. PMID: 20855820.
94. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg 90(3):892-898; discussion 898-899, 2010. PMID: 20732514.
95. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-216, 2010. PMID: 20609777.
96. Pettiford J, Erasmus J, Grubbs EG, Perrier ND. Dysphagia lucoria: Consideration for the endocrine surgeon. Surgery 147(6):890-892, 2010. e-Pub 2009. PMID: 20004435.
97. Sever M, Verstovsek S, Erasmus J, Mattiuzzi GN. Mycotic pulmonary artery aneurysm due to aspergillus infection in a patient with leukemia: Case report and review of the literature. Leuk Res 34(5):e133-136, 2010. e-Pub 2010. PMID: 20045559.
98. Betancourt SL, Martinez-Jimenez S, Rossi SE, Truong MT, Carrillo J, Erasmus JJ. Lipoid pneumonia: Spectrum of clinical and radiologic manifestations. AJR Am J Roentgenol 194(194):103-109, 2010. PMID: 20028911.
99. Ikushima H, Dong L, Erasmus J, Allen P, McAleer MF, Zhuang Y, Sasaki R, Komaki R. Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy. J Radiat Res (Tokyo) 51(4):465-471, 2010. e-Pub 2010. PMID: 20508373.
100. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(138):831-836, 2009. e-Pub 2009. PMID: 19660349.
101. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418. e1-2, 2009. e-Pub 2009. PMID: 19619787.
102. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: A multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-1387, 2009. PMID: 19464452.
103. Kased N, Erasmus JJ, Komaki R, Cox JD. Prognostic value of post treatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: A brief review. J Thorac Oncol 3(5):534-538, 2008. PMID: 18449010.
104. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Comprehensive review of superior sulcus tumors. Imaging of non-small cell lung cancer of the superior sulcus: Part 1: Anatomy, clinical manifestations, and management. Radiographics 28(2):551-660; quiz 620, 2008. PMID: 18349457.
105. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Comprehensive review of superior sulcus tumors. Imaging of non-small cell lung cancer of the superior sulcus: Part 2: Initial staging, assessment of resectability and therapeutic response. Radiographics 28(2):561-572, 2008. PMID: 18349458.
106. Liengsawangwong R, Yu TK, Sun TL, Erasmus JJ, Perkins GH, Tereffe W, Oh JL, Woodward WA, Strom EA, Salephour M, Buchholz TA. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 69(3):711-5, 2007. PMID: 17889264.
107. Bruzzi JF, Munden RF, Truong MT, Marom EM, Sabloff BS, Gladish GW, Iyer RB, Pan TS, Macapinlac HA, Erasmus JJ. PET/CT of esophageal cancer: Its role in clinical management. Radiographics 27(6):1635-1652, 2007. PMID: 18025508.
108. Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: Clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109(1):125-134, 2007. PMID: 17146785.
109. Pan T, Mawlawi O, Luo D, Liu HH, Chi PM, Mar MV, Gladish G, Truong M, Erasmus J, Liao Z, Macapinlac HA. Attenuation correction of PET cardiac data with low-dose average CT in PET/CT. Med Phys 33(10):3931-3938, 2006. PMID: 28523747.
110. Pawlik TM, Erasmus JJ, Truong MT, Macapinlac H, Ross MI, Gershenwald JE. Acne vulgaris: False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. AJR Am J Roentgenol 187(1):W117-W119, 2006. PMID: 16794124.
111. Bruzzi JF, Truong M, Zinner R, Erasmus JJ, Sabloff B, Munden R. Short-term restaging of patients with non-small cell lung cancer receiving chemotherapy. J Thorac Oncol 1(5):425-429, 2006. PMID: 17409894.
112. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: A confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 1(5):478-486, 2006. PMID: 17409902.
113. Mawlawi O, Erasmus JJ, Pan T, Cody DD, Campbell R, Lonn AH, Kohlmyer S, Macapinlac HA, Podoloff DA. Truncation artifact on PET/CT: Impact on measurements of activity concentration and assessment of a correction algorithm. AJR Am J Roentgenol 186(5):1458-1467, 2006. PMID: 16632745.
114. Truong MT, Pan T, Erasmus JJ. Pitfalls in integrated CT-PET of the thorax: Implications in oncologic imaging. J Thorac Imaging 21(2):111-22, 2006. PMID: 16770228.
115. Mawlawi O, Erasmus JJ, Munden RF, Pan T, Knight AE, Macapinlac HA, Podoloff DA, Chasen M. Quantifying the effect of IV contrast media on integrated PET/CT: Clinical evaluation. AJR Am J Roentgenol 186(2):308-319, 2006. PMID: 16423932.
116. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80(6):1988-1993, 2005. PMID: 16305830.
117. Luna A, Ribes R, Caro P, Vida J, Erasmus JJ. Evaluation of cardiac tumors with magnetic resonance imaging. Eur Radiol 15(7):1446-1455, 2005. PMID: 15627179.
118. Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff BS, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. J Thorac Cardiovasc Surg 129(6):1364-1370, 2005. PMID: 15942579.
119. Munden RF, Erasmus JJ, Smythe WR, Madewell JE, Forster KM, Stevens CW. Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: An unusual CT appearance. AJR Am J Roentgenol 184(4):1091-1095, 2005. PMID: 15788578.
120. Truong MT, Erasmus JJ, Macapinlac HA, Marom EM, Mawlawi O, Gladish GW, Sabloff BS, Bruzzi JF, Munden RF. Integrated PET/CT in patients with non-small cell lung cancer: Normal variants and pitfalls. J Comput Assist Tomogr 29(2):205-209, 2005. PMID: 15772538.
121. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23(6):1136-1143, 2005. PMID: 15718309.
122. Mawlawi O, Pan T, Erasmus JJ, Fitzpatrick M and Macapinlac HA. Comparing the quantification of static, gated, and list mode PET data acquisition of moving objects. ‎J Nucl Med 5:475, 2005.
123. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. FDG-PET imaging predicts pathologic response and survival after preoperative chemoradiation in patients with esophageal cancer. Cancer 101(8):1776-1785, 2004. PMID: 15386332.
124. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-1160, 2004. PMID: 15464463.
125. Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, Podoloff DA, Macapinlac HA. Focal FDG uptake in mediastinal brown fat mimicking malignancy: A potential pitfall resolved on PET/CT. AJR Am J Roentgenol 183(4):1127-1132, 2004. PMID: 15385319.
126. Truong MT, Sabloff BS, Munden RF, Erasmus JJ. A patient with new-onset seizure and mediastinal adenopathy. Chest 126(3):982-985, 2004. PMID: 15364782.
127. Choi YW, Munden RF, Erasmus JJ, Park KJ, Chung WK, Jeon SC, Park CK. Effects of radiation therapy on the lung: Radiologic appearances and differential diagnosis. Radiographics 24(4):985-997; discussion 998, 2004. PMID: 15256622.
128. Truong MT, Erasmus JJ, Macapinlac HA, Podoloff DA. Teflon injection for vocal cord paralysis: False-positive finding on FDG PET-CT in a patient with non-small cell lung cancer. AJR Am J Roentgenol 182(6):1587-1589, 2004. PMID: 15150014.
129. Truong MT, Erasmus JJ, Sabloff BS, Marom EM, Gladish GW, Chasen MH, Munden RF. Pericardial "sleeve" recess of right inferior pulmonary vein mimicking adenopathy: Computed tomography findings. J Comput Assist Tomogr 28(3):361-365, 2004. PMID: 15100541.
130. Rossi SE, Erasmus JJ, Volpacchio M, Franquet T, Castiglioni T, McAdams HP. "Crazy-paving" pattern at thin-section CT of the lungs: Radiologic-pathologic overview. Radiographics 23(6):1509-1519, 2003. PMID: 14615561.
131. Truong MT, Erasmus JJ, Gladish GW, Sabloff BS, Marom EM, Madewell JE, Chasen MH, Munden RF. Anatomy of pericardial recesses on multidetector CT: Implications for oncologic imaging. AJR Am J Roentgenol 181(4):1109-1113, 2003. PMID: 14500241.
132. Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS, Munden RF. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response. J Clin Oncol 21(13):2574-2582, 2003. PMID: 12829678.
133. Marom EM, Palmer SM, Erasmus JJ, Herndon JE, Zhang C, McAdams HP. Pleural effusions in lung transplant recipients: Image-guided small-bore catheter drainage. Radiology 228(1):241-245, 2003. PMID: 12832585.
134. Choi YW, Rossi SE, Palmer SM, DeLong D, Erasmus JJ, McAdams HP. Bronchiolitis obliterans syndrome in lung transplant recipients: Correlation of computed tomography findings with bronchiolitis obliterans syndrome stage. J Thorac Imaging 18(2):72-79, 2003. PMID: 12700480.
135. Franquet T, Erasmus JJ, Giménez A, Rossi S, Prats R. The retrotracheal space: Normal anatomic and pathologic appearances. Radiographics 22 Spec No:S231-S246, 2002. PMID: 12376613.
136. Giménez A, Franquet T, Erasmus JJ, Martínez S, Estrada P. Thoracic complications of esophageal disorders. Radiographics 22 Spec No:S247-S258, 2002. PMID: 12376614.
137. Marom EM, Erasmus JJ, Herndon JE, Zhang C, McAdams HP. Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. AJR Am J Roentgenol 179(1):105-108, 2002. PMID: 12076914.
138. Ravenel JG, Erasmus JJ. Azygoesophageal recess. J Thorac Imaging 17(3):219-226, 2002. PMID: 12082374.
139. Koenig TR, Munden RF, Erasmus JJ, Sabloff BS, Gladish GW, Komaki R, Stevens CW. Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 178(6):1383-1388, 2002. PMID: 12034601.
140. Gladish GW, Sabloff BM, Munden RF, Truong MT, Erasmus JJ, Chasen MH. Primary thoracic sarcomas. Radiographics 22(3):621-637, 2002. PMID: 12006691.
141. Ham S, Gladish GW, Erasmus JJ. Hepatic segments II and III mimicking a lung mass: diagnosis of a normal variant using reformatted multiplanar CT images. J Comput Assist Tomogr 26(3):365-367, 2002. PMID: 12016364.
142. McAdams HP, Erasmus JJ, Palmer SM. Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: Incidence, radiologic features, and clinical importance. Radiology 218(1):233-241, 2001. PMID: 11152808.
143. Aloia T, Bepler G, Harpole D, Goodman PC, McAdams HP, Erasmus JJ, Herndon JE, Patz EF. Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities. Cancer Detect Prev 25(4):336-43, 2001. PMID: 11531010.
144. Crotty EJ, McAdams HP, Erasmus JJ, Sporn TA, Roggli VL. Epithelioid hemangioendothelioma of the pleura: Clinical and radiologic features. AJR Am J Roentgenol 175(6):1545-1549, 2000. PMID: 11090371.
145. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: Radiologic and pathologic manifestations. Radiographics 20(5):1245-1259, 2000. PMID: 10992015.
146. Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 175(1):245-249, 2000. PMID: 10882281.
147. Marom EM, Erasmus JJ, Patz EF. Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer 28(3):187-202, 2000. PMID: 10812188.
148. Rossi SE, McAdams HP, Erasmus JJ, Sporn TA. A 63-year-old woman with a 2-month history of dyspnea. Chest 117(5):1505-1507, 2000. PMID: 10807843.
149. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics 20(1):43-58, 2000. PMID: 10682770.
150. Erasmus JJ, McAdams HP, Connolly JE. Solitary pulmonary nodules: Part II. Evaluation of the indeterminate nodule. Radiographics 20(1):59-66, 2000. PMID: 10682771.
151. Rossi SE, Erasmus JJ, McAdams HP, Donnelly LF. Pictorial essay: Thoracic manifestations of neurofibromatosis-I. AJR Am J Roentgenol 173(6):1631-1638, 1999. PMID: 10584812.
152. Erasmus JJ, McAdams HP, Farrell MA, Patz EF. Pulmonary nontuberculous mycobacterial infection: Radiologic manifestations. Radiographics 19(6):1487-1505, 1999. PMID: 10555671.
153. Erasmus JJ, McAdams HP, Patz EF. Non-small cell lung cancer: FDG-PET imaging. J Thorac Imaging 14(4):247-256, 1999. PMID: 10524805.
154. Layfield LJ, Liu K, Erasmus JJ. Radiographic determined diameter, pathologic diameter, and reactive zone surrounding pulmonary neoplasms: Implications for transthoracic fine-needle aspiration of pulmonary neoplasms. Diagn Cytopathol 21(4):250-252, 1999. PMID: 10495317.
155. Marom EM, McAdams HP, Palmer SM, Erasmus JJ, Sporn TA, Tapson VF, Davis RD, Goodman PC. Cystic fibrosis: Usefulness of thoracic CT in the examination of patients before lung transplantation. Radiology 213(1):283-288, 1999. PMID: 10540673.
156. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF. Staging non-small cell lung cancer with whole-body PET. Radiology 212(3):803-809, 1999. PMID: 10478250.
157. Connolly JE, Erasmus JJ, Patz EF. Thoracic manifestations of breast carcinoma: Metastatic disease and complications of treatment. Clin Radiol 54(8):487-494, 1999. PMID: 10484214.
158. Farrell M, McAdams HP, Erasmus JJ. A 27-year-old woman with cough, dyspnea, and wheezing. Chest 116(2):557-559, 1999. PMID: 10453888.
159. Patz EF, Erasmus JJ. Positron emission tomography imaging in lung cancer. Clin Lung Cancer 1(1):42-49, 1999. PMID: 14725748.
160. Patz EF, Erasmus JJ, McAdams HP, Connolly JE, Marom EM, Goodman PC, Leder RA, Keogan MT, Herndon JE. Imaging lung cancer staging and management: Comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology 212(1):56-60, 1999. PMID: 10405720.
161. Marom EM, Patz EF, Erasmus JJ, McAdams HP, Goodman PC, Herndon JE. Malignant pleural effusions: Treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 210(1):277-281, 1999. PMID: 9885620.
162. Marom EM, McAdams HP, Erasmus JJ, Goodman PC. Pictorial essay: The many faces of pulmonary aspiration. AJR Am J Roentgenol 172(1):121-128, 1999. PMID: 9888751.
163. Erasmus JJ, McAdams HP, Goodman PC. Diagnosis please, case 5: Esophageal mucocele after surgical bypass of the esophagus. Radiology 209(3):757-760, 1998. PMID: 9844670.
164. McAdams HP, Palmer SM, Erasmus JJ, Patz EF, Connolly JE, Goodman PC, Delong DM, Tapson VF. Bronchial anastomotic complications in lung transplant recipients: Virtual bronchoscopy for noninvasive assessment. Radiology 209(3):689-695, 1998. PMID: 9844660.
165. McAdams HP, Erasums JJ, Patz EF, Goodman PC, Coleman RE. Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET. J Comput Assist Tomogr 22(4):601-4, 1998. PMID: 9676452.
166. Erasmus JJ, McAdams HP, Patz EF, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 170(5):1369-1373, 1998. PMID: 9574618.
167. Patz EF, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Gilkeson RC, Herndon J. Sclerotherapy for malignant pleural effusions: A prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 113(5):1305-1311, 1998. PMID: 9596311.
168. Patz EF, Goodman PC, Erasmus JJ. Percutaneous drainage of pleural collections. J Thorac Imaging 13(2):83-92, 1998. PMID: 9556285.
169. Schreiber EG, Erasmus JJ, McAdams HP. Roentgenogram-of-the-month: A patient with newly diagnosed melanoma and pulmonary nodules. Chest 113(3):826-829, 1998. PMID: 9515864.
170. Wilczynski SW, Erasmus JJ, Petros WP, Vredenburgh JJ, Folz RJ. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med 157(2):565-573, 1998. PMID: 9476874.
171. Erasmus JJ, McAdams HP, Patz EF, Goodman PC, Coleman RE. Thoracic FDG PET: State of the art. Radiographics 18(1):5-20, 1998. PMID: 9460106.
172. Erasmus JJ, McAdams HP, Tapson VF, Murray JG, Davis RD. Radiologic issues in lung transplantation for end-stage pulmonary disease. AJR Am J Roentgenol 169(1):69-78, 1997. PMID: 9207503.
173. Murray JG, Patz EF, Erasmus JJ, Gilkeson RC. CT appearance of the pleural space after talc pleurodesis. AJR Am J Roentgenol 169(1):89-91, 1997. PMID: 9207506.
174. Erasmus JJ, Patz EF, McAdams HP, Murray JG, Herndon J, Coleman RE, Goodman PC. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168(5):1357-1360, 1997. PMID: 9129444.
175. McAdams HP, Murray JG, Erasmus JJ, Goodman PC, Tapson VF, Davis RD. Telescoping bronchial anastomoses for unilateral or bilateral sequential lung transplantation: CT appearance. Radiology 203(1):202-206, 1997. PMID: 9122393.
176. Murray JG, Erasmus JJ, Bahtiarian EA, Goodman PC. Talc pleurodesis simulating pleural metastases on 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168(2):359-360, 1997. PMID: 9016206.
177. Erasmus JJ, McAdams HP, Carraway MS. Roentgenogram-of-the-month: A 63-year-old woman with weight loss and multiple lung nodules. Chest 111(1):236-238, 1997. PMID: 8996023.
178. Brodwater B, Erasmus J, McAdams HP, Dodd L. Case report. Pericardial hemangioma. J Comput Assist Tomogr 20(6):954-956, 1996. PMID: 8933798.
179. Erasmus JJ, McAdams HP, Patz EF, Murray JG, Pinkard NB. Calcifying fibrous pseudotumor of pleura: Radiologic features in three cases. J Comput Assist Tomogr 20(5):763-765, 1996. PMID: 8797908.
180. McAdams HP, Erasmus J, Crockett R, Mitchell J, Godwin JD, McDermott VG. The hepatopulmonary syndrome: Radiologic findings in 10 patients. AJR Am J Roentgenol 166(6):1379-1385, 1996. PMID: 8633451.
181. Murray JG, McAdams HP, Erasmus JJ, Patz EF, Tapson V. Complications of lung transplantation: Radiologic findings. AJR Am J Roentgenol 166(6):1405-1411, 1996. PMID: 8633454.
182. Erasmus JJ, Goodman PC. Focal pulmonary edema: A complication of endovascular stent dilatation of pulmonary artery stenoses. AJR Am J Roentgenol 165(4):821-823, 1995. PMID: 7676974.
183. McAdams HP, Erasmus J. Chest case of the day. Williams-Campbell syndrome. AJR Am J Roentgenol 165(1):190-191, 1995. PMID: 7785587.
184. Betancourt-Cuellar SL, Benveniste MK, Palacio DP, Erasmus JJ. Esophageal cancer: TNM staging. Clinics of North America.

Invited Articles

1. Godoy MCB, Odisio EGLC, Erasmus JJ, Chate RC, Dos Santos RS, Truong MT. Understanding Lung-RADS 1.0: A case-based review. Semin Ultrasound CT MR 39(3):260-272, 2018. e-Pub 2018. PMID: 29807636.
2. Godoy MCB, Odisio EGLC, Truong MT, de Groot PM, Shroff GS, Erasmus JJ. Pulmonary nodule management in lung cancer screening: A pictorial review of lung-RADS version 1.0. Radiol Clin North Am 56(3):353-363, 2018. PMID: 29622071.
3. Carter BW, Godoy MC, Wu CC, Erasmus JJ, Truong MT. Current controversies in lung cancer staging. J Thorac Imaging 31(4):201-14, 2016. PMID: 27306388.
4. Carter BW, Erasmus JJ. Acute thoracic findings in oncologic patients. J Thorac Imaging 30(4):233-46, 2015. e-Pub 2015. PMID: 25803363.
5. Betancourt-Cuellar SL, Carter BW, Palacio D, Erasmus JJ. Pitfalls and limitations in non-small cell lung cancer staging. Semin Roentgenol 50(3):175-82, 2015. e-Pub 2015. PMID: 26002237.
6. de Groot PM, Carter BW, Betancourt Cuellar SL, Erasmus JJ. Staging of lung cancer. Clin Chest Med 36(2):179-196, 2015. e-Pub 2015. PMID: 26024599.
7. Huynh TT, Broadbent KC, Jacob AD, James S, Erasmus JJ. Screening for carotid artery stenosis. Semin Roentgenol 50(2):127-38, 2015. e-Pub 2014. PMID: 25770343.
8. Carter BW, Glisson BS, Truong MT, Erasmus JJ. Small cell lung carcinoma: Staging, imaging, and treatment considerations. Radiographics 34(6):1707-21, 2014. PMID: 25310425.
9. Erasmus JJ, Mawlawi O, Howard B, Patz EF. PET-CT: Current applications and new developments in the thorax. Semin Respir Crit Care Med 35(1):145-56, 2014. e-Pub 2014. PMID: 24481767.
10. Godoy MC, Bruzzi JF, Viswanathan C, Truong MT, Guimarães MD, Hofstetter WL, Erasmus JJ, Marom EM. Multimodality imaging evaluation of esophageal cancer: Staging, therapy assessment and complications. Abdom Imaging 38(5):974-93, 2013. e-Pub 2013. PMID: 23677485.
11. Boiselle PM, Erasmus JJ, Kauczor HU, Li K, Patz E. Expert opinion: The future role of cardiothoracic radiologists in molecular imaging. J Thorac Imaging 28(1):2, 2013. PMID: 23249965.
12. Erasmus JJ, Macapinlac HA. Low-sensitivity FDG-PET studies: Less common lung neoplasms. Semin Nucl Med 42(4):255-60, 2012. PMID: 22681674.
13. Welsh J, Amini A, Likhacheva A, Erasmus JJ, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Update: Modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep 13(3):157-67, 2011. PMID: 21365188.
14. Boiselle PM, Erasmus JJ, Ko JP, Ravenel JG, Vlahos I. Expert opinion: Lung cancer staging. J Thorac Imaging 26(2):85, 2011. PMID: 21508729.
15. Truong MT, Viswanathan C, Erasmus JJ. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging 26(2):132-46, 2011. PMID: 21508735.
16. Erasmus JJ, Rohren E, Swisher SG. Prognosis and reevaluation of lung cancer by positron emission tomography imaging. Proc Am Thorac Soc 6(2):171-179, 2009. PMID: 19349485.
17. Erasmus JJ, Rohren EM, Hustinx R. PET and PET/CT in the diagnosis and staging of esophageal and gastric cancers. PET Clin 3(2):135-45, 2008. e-Pub 2008. PMID: 27156458.
18. Erasmus JJ, Sabloff BS. CT, positron emission tomography, and MRI in staging lung cancer. Clin Chest Med 29:39-57, 2008. PMID: 18267183.
19. Erasmus JJ, Macapinlac HA, Swisher SG. Positron emission tomography imaging in nonsmall-cell lung cancer. Cancer 110(10):2155-2168, 2007. PMID: 17896784.
20. Bruzzi JF, Truong MT, Macapinlac H, Munden RF, Erasmus JJ. Integrated CT-PET imaging of esophageal cancer: Unexpected and unusual distribution of distant organ metastases. Curr Probl Diagn Radiol 36:21-29, 2007. PMID: 17198889.
21. Erasmus JJ, Munden RF. The role of integrated computed tomography positron-emission tomography in esophageal cancer: Staging and assessment of therapeutic response. Semin Radiat Oncol 17(1):29-37, 2007. PMID: 17185195.
22. Munden RF, Macapinlac HA, Erasmus JJ. Esophageal cancer: The role of integrated CT-PET in initial staging and response assessment after pre-operative therapy. J Thorac Imaging 21(2):137-145, 2006. PMID: 16770230.
23. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: Role of integrated CT-PET imaging. J Thorac Imaging 21(2):146-53, 2006. PMID: 16770231.
24. Erasmus JJ, Truong MT, Munden RF. CT, MR, and PET imaging in staging of non-small-cell lung cancer. Semin Roentgenol 40:126-142, 2005. PMID: 15898410.
25. Sabloff BS, Wistuba II, Erasmus JJ. Cystic bronchioloalveolar cell carcinoma. J Thorac Imaging 20:110-114, 2005. PMID: 15818211.
26. Sabloff BS, Truong MT, Wistuba II, Erasmus JJ. Bronchioalveolar cell carcinoma: Radiologic appearance and dilemmas in the assessment of response. Clin Lung Cancer 6:108-112, 2004. PMID: 15476596.
27. Truong MT, Erasmus JJ, Marom EM, Munden RF. Imaging evaluation in the diagnosis and staging of malignant pleural mesothelioma. Semin Roentgenol 39:386-396, 2004. PMID: 15372752.
28. Erasmus JJ, McAdams HP, Rossi SE. Drug-induced lung injury. Semin Roentgenol 37:72-81, 2002. PMID: 11987768.
29. Erasmus JJ, McAdams HP, Rossi SE. High-resolution CT of drug-induced lung disease. Radiol Clin North Am 40:61-72, 2002. PMID: 11813820.
30. Marom EM, Erasmus JJ, Pass HI, Patz EF. The role of imaging in malignant pleural mesothelioma. Semin Oncol 29:26-35, 2002. PMID: 11836666.
31. Collins J, Reddy GP, Mullan BF, Nath HP, Green CE, Batra PV, Wexler L, Boxt LM, Duerinckx AJ, Erasmus JJ, Kazerooni EA, Kazerooni EA. A curriculum in cardiothoracic radiology for medical students, with goals and objectives. Acad Radiol 8:1247-1251, 2001. PMID: 11770921.
32. Erasmus JJ, Goodman PC, Patz EF. Management of malignant pleural effusions and pneumothorax. Radiol Clin North Am 38:375-383, 2000. PMID: 10765395.
33. Erasmus JJ, McAdams HP, Donnelly LF, Spritzer CE. MR imaging of mediastinal masses. Magn Reson Imaging Clin N Am 8:59-89, 2000. PMID: 10730236.
34. Erasmus JJ, McAdams HP, Rossi S, Kelley MJ. Percutaneous management of intrapulmonary air and fluid collections. Radiol Clin North Am 38:385-393, 2000. PMID: 10765396.
35. Kazerooni EA, Collins J, Reddy GP, Nath HP, Batra PV, Boxt LM, Duerinckx AJ, Erasmus JJ, Fishman JE, Leung AN, Tarver RD, Wexler L, Winer-Muram HT. A curriculum in chest radiology for diagnostic radiology residency, with goals and objectives. Acad Radiol 7:730-743, 2000. PMID: 10987336.
36. Rossi S, Erasmus JJ, McAdams HP. Thoracic manifestations of tuberculosis. Contemporary Diagnostic Radiology 23:1-6, 2000.
37. Rossi S, McAdams HP, Erasmus JJ. Intrathoracic manifestations of non-tuberculous mycobacterial infection. Contemporary Diagnostic Radiology 23:1-6, 2000.
38. Connolly JE, McAdams HP, Erasmus JJ, Rosado-de-Christenson ML. Opportunistic fungal pneumonia. J Thorac Imaging 14:51-62, 1999. PMID: 9894953.
39. Erasmus JJ, Patz EF. Positron emission tomography imaging in the thorax. Clin Chest Med 20:715-724, 1999. PMID: 10587793.
40. Erasmus JJ, Patz EF. Treatment of malignant pleural effusions. Curr Opin Pulm Med 5:250-255, 1999. PMID: 10407696.
41. Davey IC, Davey NC, Erasmus JJ. State-of-the-art imaging of pulmonary embolic disease. Postgrad. Radiology 18:152-165, 1998.
42. Erasmus JJ, Patz EF. Imaging of the solitary pulmonary nodule. Semin Respir Crit Care Med 19:483-491, 1998.
43. McAdams HP, Erasmus J, Winter JA. Radiologic manifestations of pulmonary tuberculosis. Radiol Clin North Am 33:655-678, 1995. PMID: 7610237.
44. Patz EF, Swensen SJ, Erasmus J. Pulmonary manifestations of nontuberculous mycobacterium. Radiol Clin North Am 33:719-729, 1995. PMID: 7610241.

Editorials

1. Erasmus JJ, Vlahos I. Editorial commentary: Baseline radiomic signature to estimate overall survival in patients with NSCLC. J Thorac Oncol 18(5):556-558, 2023. PMID: 37087116.
2. Carter BW, Godoy MC, Erasmus JJ. Predicting malignant nodules from screening CTs. J Thorac Oncol 11(12):2045-2047, 2016. PMID: 27866632.
3. Gold KA, Erasmus JJ. FDG-PET/CT as a predictor of outcome in EGFR-Mutant non-small-cell lung cancer. J Thorac Oncol 10(8):1131-2, 2015. PMID: 26200266.
4. Erasmus JJ. Expert opinion: How can cardiothoracic radiologists ensure that we will play a major role in the future of molecular imaging?. J Thorac Imaging 28(1):2, 2013.
5. Stewart DJ, Erasmus JJ. Editorial comment: Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor. J Thorac Oncol 6(7):1149-51, 2011. PMID: 21847039.
6. Erasmus JJ. Expert opinion: If you were given the opportunity to make one modification to the recently revised lung cancer staging system, what would it be and why?. J Thorac Imaging 26:85, 2011.
7. Gladish GW, Erasmus JJ. Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 5(6):759-760, 2010. PMID: 20502266.
8. Patz EF, Erasmus JJ. Editorial comment: Positron emission tomography in the lung 25 years after publication in the inaugural issue of the Journal of Thoracic Imaging. J Thorac Imaging 25(1):39-40, 2010. PMID: 20160601.
9. Erasmus JJ. Fluorodeoxyglucose uptake predicts survival in a CT screening trial. J Thorac Oncol 4(11):1305-1306, 2009. PMID: 19861902.
10. Erasmus JJ. Editorial comment: PET is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small cell lung cancer. Abstracts in Hematology & Oncology 6:9-10, 2003.
11. Erasmus JJ. Editorial comment: PET may prove to be innovation for staging patients with NSCLC. Abstracts in Hematology & Oncology 4:14, 2001.

Abstracts

1. Minnix JA, Kypriotakis G, Erasmus J, Beneventi D, Karam-Hage M, Carpenter K, Volk RJ, Carter B, Godoy M, Strange C, Shih YT, Cui Y, Green CE, Robinson JD, Cinciripini PM. Project luna: Optimizing the effectiveness of a smoking cessation intervention in the low-dose CT lung cancer screening setting. Society For Research On Nicotine & Tobacco, SRNT 2024 Conference, 2024.
2. Tsakiridis T, Skinner HD, Hu C, Santana-Davila R, Lu B, Erasmus JJ, Doemer A, Videtic GM, Coster J, Yang X, Lee R, Werner-Wasik M, Schaner PE, McCormack SE, Esparaz B, McGarry R, Bazan JG, Struve T, Bradley JD. Initial reporting of NRG-LU001, randomized phase II trial of concurrent chemoradiotherapy +/- metformin HCL in locally advanced non-small cell lung cancer (NSCLC). American Society of Clinical Oncology Annual Meeting, 2019.
3. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa A, Badgwell BD, Hofstetter WL. Predictors of mediastinal involvement after neoadjuvant chemoradiation in adenocarcinoma of the gastroesophageal junction. The Southern Thoracic Surgical Association's 65th Annual Meeting, 2018.
4. Lowenstein LM, Godoy M, Erasmus J, Zirari Z, Bennett A, Leal VB, Housten AJ, Volk RJ. Alternative delivery model for the shared decision making visit for lung cancer screening: A pilot study. 40th Annual Meeting of the Society for Medical Decision Making, 2018.
5. Lowenstein LM, Godoy M, Zirari Z, Leal VB, Housten AJ, Erasmus JJ, Volk RJ. A pilot study testing the effectiveness, feasibility, and fidelity of implementing a shared decision making visit for lung cancer screening in the screening setting. 10th Annual Conference on the Science of Dissemination and Implementation, 2017.
6. Skoulidis F, Hellmann MD, Awad MM, Rizvi H, Carter BW, Denning W, Elamin Y, Zhang J, Leonardi GC, Halpenny D, Plodkowski A, Long N, Erasmus JJ, Papadimitrakopoulou V, Wong K, Wistuba II, Janne PA, Rudin CM, Heymach J. STK11/LKB1 co-mutations to predict for de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma. American Society of Clinical Oncology Annual Meeting, 2017.
7. Wei X, Allen P, Erasmus J, Blumenschein G, Godoy M, Lee JJ, O'Reilly M, Welsh J, Cox J, Hong WK, Komaki R. PET metabolic tumor response by PERCIST reliably predicts local regional control in locally advanced non-small cell lung cancer after concurrent chemoradiation therapy with erlotinib. American Society for Radiation Oncology (ASTRO) 57th Annual Meeting, 2015.
8. Sorensen J, Duran C, Stingo F, Wei W, Rao A, Zhang L, Court L, Erasmus J, Godoy M. Dual-energy chest CT: The effects of virtual monochromatic reconstructions on texture analysis features. Med Phys 42(6):3214, 2015.
9. Betancourt Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Swisher SG, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal cancer: Does FDG-PET/CT have a role. 114th Annual Meeting of the American Roentgen Ray Society, 2014.
10. Francis AM, Correa AM, Betancourt-Cuellar SL, Kim JY, Sepesi B, Ajani JA, Komaki R, Erasmus JJ, Maru D, Munden RF, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Hofstetter WL, Swisher SG. Esophageal tumor thickness on computed tomography as a predictor of residual tumor in esophageal adenocarcinoma following preoperative chemoradiation. 9th Annual Academic Surgical Congress, 2014.
11. Evans JD, Gomez DR, Chang JY, Gladish GW, Erasmus JJ, Rebueno N, Banchs J, Komaki R, Welsh JW. Cardiac isodose distributions and increases in focal 18F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic ablative radiotherapy. American Society of Radiation Oncology 55th Annual Meeting, 2013.
12. Sepesi B, Correa AM, Pataer A, Kalhor N, Bekele BN, Erasmus JJ, Hofstetter WL, Kim E, Komaki R, Mehran R, Moran CA, Papadimitrakopoulou V, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, William W, Wistuba I, Swisher SG. The impact of histopathologic response on pathologic TNM lung cancer staging system (AJCC Seventh) following neoadjuvant chemotherapy. Society of Thoracic Surgeons 49th Annual Meeting, 2013.
13. Marom EM, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. CT findings predicting invasiveness of thymoma. 40th Congress of the International Society of Oncology and Biomarkers, 2012.
14. Erasmus JJ. Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC). Cancer Research 72(8 Supplement):4819, 2012.
15. Marks JL, Hofstetter W, Correa A, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus JJ, Chang J, Maru D, Lee JH, Lee, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Society of Thoracic Surgery 48th Annual Meeting, 2012.
16. Erasmus JJ. Specific forms of mutant KRAS predict patient benefit from targeted therapy in the BATTLE-1 clinical trial in advanced non-small cell lung cancer. Cancer Research 71(8 Supplement):955, 2011.
17. Amini A, Welsh JW, Yang J, McBurney ML, Williamson1 RT, Karhade M, Allen PK, Erasmus JJ, Dong L, Liao Z. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. American Society of Clinical Oncology Annual Meeting, 2011.
18. Xiang Z, Wen H, Erasmus JJ, O’Reilly M, Komaki R,Cox JD, Chang JY. FDG uptake predicts recurrence and survival in patients with unresectable stage III non-small cell lung cancer treated with 74 Gy (RBE) proton therapy and chemotherapy. American Society of Clinical Oncology Annual Meeting, 2011.
19. Kim MP, Correa A, Moran C, Erasmus J, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA. Resection of lung cancer in lymphoma survivors. The Society of Thoracic Surgeons 46th Annual Meeting, Fort Lauderdale, FL, 2010.
20. Gomez DR, Gladish GW, Wei X, Allen P, Cox JD, O'Reilly M, Erasmus JJ, Fossella FV, Komaki R. Pretreatment positron emission tomography scan standardized uptake value as a prognostic variable for overall survival in limited-stage small cell lung cancer. American Society of Clinical Oncology Annual Meeting, 2010.
21. Wei X, Allen PK, Blumenschein G, Hong WK, Herbst RS, O'Reily M, Heymach JV, Erasmus JJ, Lee J, Komaki R. The advantage of using PET SUV to evaluate tumor response by RECIST criteria in patients with stage IIIA/B non-small cell lung cancer after concurrent chemotherapy and tarceva with radiotherapy. Annual Meeting of the American Society for Radiation Oncology, 2010.
22. Hofstetter W, Maru D, Correa A, Shah N, Lee J, Ajani A, Erasmus JJ, Komaki R, Anandasabathy S, Swisher SG. Salvage resection for esophageal adenocarcinoma after failed definitive chemoradiation. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, 2009.
23. Johnson ED, Hanneken JM, Taylor S, Erasmus JJ, Karp D. Long term survivors (LTS) in advanced NSCLC treated non-surgically: treatment patterns and paradigms for success. International Association for the Study of Lung Cancer 13th World Conference on Lung Cancer, San Francisco, California, 2009.
24. Tam A, Kim ES, Herbst R, Wistuba II, Lee JJ, Alden C, Tsao A, Blumenschein G, Erasmus JJ, Hicks M, Hong WK, Gupta S. Personalized lung cancer therapy: Safety and adequacy of image-guided small-caliber core needle biopsy for evaluation of multiple molecular biomarkers. International Association for the Study of Lung Cancer 13th World Conference on Lung Cancer, San Francisco, CA, 2009.
25. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus JJ, Lee JK, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer. Southern Thoracic Surgical Association 56th Annual Meeting, 2009.
26. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus JJ, Gokaslan Z, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Long-term survival with surgical management for superior sulcus tumors with vertebral resection. 88th Annual Meeting of the American Association for Thoracic Surgery, 2008.
27. Kassis KS, Vaporciyan AA, Swisher SG, Correa AM, Bekele N, Erasmus JJ, Hofstetter W, Komaki R, Mehran R, Moran CA, Pisters K, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. 88th Annual Meeting of the American Association for Thoracic Surgery, 2008.
28. Bolton WD, Hofstetter W, Francis A, Correa AM, Ajani JA, Bhutani B, Erasmus JJ, Komaki R, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL Stephen, Swisher SG. Impact of tumor length and submucosal involvement on the long-term survival of pT1 early stage esophageal adenocarcinoma. 88th Annual Meeting of the American Association for Thoracic Surgery, 2008.
29. Mawlawi O, Truong M, Marom E, Pan T, Sabloff B, Bruzzi J, Erasmus JJ, Yeung H, Macapinlac HA. Clinical evaluation of 2D versus 3D whole body imaging performed on two different scanners with different detectors. 54th Annual Meeting of the Society of Nuclear Medicine, 2007.
30. Liengsawangwong R, Yu TK, Sun TL, Erasmus JJ, et al. Treatment optimization using computed tomography delineated targets should be used for supraclavicular radiation in breast cancer. 48th Annual American Society for Therapeutic Radiology and Oncology, 2006.
31. Mawlawi O, Erasmus JJ, Qiao F, Pan T. Gross tumor volume measurement of simulated lung nodules using PET imaging. 48th Annual Meeting of the American Association of Physicists in Medicine, 2006.
32. Pan T, Mawlawi O, Nehmeh SA, Erdi YE, Chi PM, Lou D, Truong M, Erasmus JJ, Macapinlac HA. New low dose cine CT for quantitation of the PET data in the thorax on PET/CT. 53rd Annual Meeting of the Society of Nuclear Medicine, 2006.
33. Mawlawi O, Pan T, Baghaei H, Swanston N, Darensbourg B, Erasmus JJ, Macapinlac HA. A comparison of lesion detectability among four different PET scanners. 53rd Annual Meeting of the Society of Nuclear Medicine, 2006.
34. Pan T, Mawlawi O, Nehmeh SA, Erdi YE, Chi PM, Lou D, Truong M, Erasmus JJ, Macapinlac HA. Attenuation correction of cardiac PET data with respiration-averaged CT on PET/CT. 53rd Annual Meeting of the Society of Nuclear Medicine, 2006.
35. Gladish GW, Erasmus JJ, Sabloff BS, et al. Investigation of the feasibility of the use of normal saline as a negative intravascular contrast agent in thoracic CT. 1st World Congress of Thoracic Imaging and Diagnosis of Chest Disease, Florence, Italy, 2005.
36. Glisson BS, Blumenschein G, Francisco, Erasmus JJ, Zinner R, Kies M. Phase II trial of gefitinib in patients with incurable salivary gland cancer. 41st Annual Congress of the American Society of Clinical Oncology, 2005.
37. Mawlawi O, Erasmus JJ, Pan T, Bradley WM, Qiao F, Macapinlac HA. Initial comparison of clinical image quality between the discovery ST and the new GE research PET-CT scanner. Annual Congress of the European Association of Nuclear Medicine, 2005.
38. Rice D, Vaporciyan A, Stevens C, Wu J, Walsh G, Swisher S, Hofstetter W, Erasmus JJ, Smythe RW. Extended surgical staging for potentially resectable malignant mesothelioma. 41st Annual Meeting of the Society of Thoracic Surgeons, 2005.
39. Swisher S, Macapinlac HA, Erasmus JJ, Munden RF. FDG-PET imaging in esophageal cancer. Annual Conference of the Academy of Molecular Imaging, 2005.
40. Bruzzi JF, Erasmus JJ, et al. Can restaging PET/CT predict suitability for resection of esophageal cancer following neoadjuvant chemoradiotherapy?. 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2005.
41. Bruzzi J, Truong MT, Erasmus JJ, et al. 18-FDG PET/CT in the evaluation of benign and malignant pleural effusions. 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2005.
42. Truong MT, Erasmus JJ, Swisher S, et al. Integrated CT-PET in restaging of patients with potentially resectable esophageal malignancy after induction chemoradiation. 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2005.
43. Truong MT, Bruzzi J, Erasmus JJ, et al. 18-FDG PET/CT in the evaluation of radiation injury versus tumor recurrence in patients with non-small cell lung cancer. 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2005.
44. Bruzzi J, Truong MT, Gladish GW, Sabloff BS, Marom EM, Erasmus JJ. Unusual and uncommon presentations of esophageal cancer metastases on PET/CT imaging. 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2005.
45. Mawlawi O, Pan T, Erasmus JJ, et al. Quantifying the effect of intravenous contrast media on PET/CT imaging: Clinical evaluation. 51st Annual Meeting of the Society of Nuclear Medicine, 2004.
46. Mawlawi O, Pan T, Cody DD, Erasmus JJ, et al. Evaluation of a new CT truncation correction algorithm for accurate quantification of PET/CT images. 51st Annual Meeting of the Society of Nuclear Medicine, 2004.
47. Swisher S, Erasmus JJ, Maish M, et al. PET predicts pathologic response and long-term survival following preoperative chemoradiation in esophageal cancer. 40th Annual Meeting of American Society of Clinical Oncology, 2004.
48. Swisher SG, Erasmus JJ, et al. PET predicts pathologic response and long-term survival following preoperative chemoradiation in esophageal cancer. Gastrointestinal Cancer Symposium, 2004.
49. Truong MT, Erasmus JJ, Munden RF, et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: A potential pitfall resolved on PET-CT. 51st Annual Meeting of the Society of Nuclear Medicine, 2004.
50. Truong MT, Erasmus JJ, Munden RF, et al. Comparison of multidetector CT and MRI in the preoperative localization of hyperfunctioning parathyroid glands. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2004.
51. Swisher SG, Maish M, Erasmus JJ, et al.. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Scientific Program of the Southern Thoracic Society 40th Annual Meeting, 2004.
52. Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS, Munden RF. Inter-observer and intra-observer variability in measurement of 41 non-small cell carcinoma lung lesions: Implications for assessment of tumor response. Proceedings of the American Society of Clinical Oncology, 2003.
53. Mawlawi O, Kohlmyer S, Macapinlac H, Erasmus JJ, et al. Evaluation of the relationship between the injected dose, body mass index, NECR, scan duration and image quality using the GE Discovery ST (DST) PET/CT scanner in 3D mode. Institute for Clinical PET, From Translational Research to Clinical Applications: State-of-the-Art PET and PET-CT, 2003.
54. Mawlawi O, Macapinlac H, Erasmus JJ, et al. Effect of CT current on the qualitative and quantitative assessment of PET/CT images. Annual Congress of the European Association of Nuclear Medicine Meeting, 2003.
55. Sasaki R, Komaki R, Macapinlac H, Erasmus JJ, et al. SUV by FDG-PET predicts outcome of non-small cell lung cancer. Scientific program of the Southern Thoracic Society of the 45th Annual Meeting of The American Society for Therapeutic Radiology and Oncology, 2003.
56. Giminez A, Erasmus JJ, Franquet H, McAdams HP, Rossie SE, Madrid M. Pleural disease: Beyond malignant mesothelioma. European Congress of Radiology, 2002.
57. Franquet T, Erasmus JJ, Gimenez A, Prats R. The retrotracheal space: Normal anatomy and pathological appearances. European Congress of Radiology, 2002.
58. Marom EM, Erasmus JJ, Herndon JE, Zhang C, McAdams HP. Efficacy of image-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. Scientific Program at the 20th Annual Meeting and Postgraduate Course of the Society of Thoracic Radiology, 2002.
59. Erasmus JJ, Munden RF, Gladish GW, et al.. Inter-observer and intra-observer variability in measurement of 41 non-small cell carcinoma lung lesions: Implications for assessment of tumor response. Scientific Program at the 20th Annual Meeting and Postgraduate Course of the Society of Thoracic Radiology, 2002.
60. Mawlawi O, Macapinlac H, Erasmus JJ, et al.. Transformation of CT to PET attenuation in the presence of IV contrast. Scientific Program at the European Association of Nuclear Medicine Meeting, 2002.
61. Marom EM, Palmer SM, Erasmus JJ, et al.. Small-bore catheter drainage of pleural effusions in lung transplant recipients. Scientific Program at the 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2001.
62. Sabloff BS, Munden RF, Gladish GW, Truong MT, Erasmus JJ. Comparison of normal anatomic structures using digital radiography (DR) versus conventional film screen. Scientific Program at the 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2001.
63. Marom EM, Erasmus JJ, Herndon JE, Zhang C, McAdams HP. Efficacy of image-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. Scientific Program at the 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2001.
64. Gimenez A, Erasmus JJ, Gladish GW, et al.. Inter-observer variability in measurement of NSCLC lung lesions: Implications for assessment of tumor response. Scientific Program at the 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2001.
65. Rossi S, Erasmus JJ, McAdams HP. FDG-PET imaging of pleural effusions in patients with non-small cell lung cancer. Scientific Program at the 18th Annual Meeting and Postgraduate Course of the Society of Thoracic Radiology, 2000.
66. Rossi S, McAdams HP, Erasmus JJ. Thoracic manifestations of neurofibromatosis I: Findings in 115 patients. Scientific Program at the 100th Annual Meeting of the American Roentgen Ray Society, 2000.
67. Marom EM, Patz EF, Erasmus JJ. Palliative treatment of malignant pleural effusions: Value of small-bore catheter thorocostomy and talc sclerotherapy. Scientific Program at the 16th Annual Meeting and Postgraduate Course of the Society of Thoracic Radiology Course, 1998.
68. McAdams HP, Erasmus JJ, Patz EF. Evaluation of patients with round atelectasis using 2-[F-18]-2-deoxy-D-glucose positron emission tomography (FDG-PET). Scientific Program at the 98th Annual Meeting of the American Roentgen Ray Society, 1998.
69. Erasmus JJ, McAdams HP, Patz EF. FDG-PET imaging of pulmonary carcinoid tumors. Scientific Program at the 98th Annual Meeting of the Roentgen Ray Society, 1998.
70. Marom EM, McAdams HP, Erasmus JJ. Staging non-small cell lung cancer with whole body positron emission tomography. Scientific Program at the 48th Annual Scientific Assembly and Annual Meeting of the Radiological Society of North America, 1998.
71. Marom EM, McAdams HP, Erasmus JJ. Value of chest CT in the pre-transplant evaluation of patients with cystic fibrosis. Scientific Program at the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 1998.
72. Patz EF, Erasmus JJ, McAdams HP. Thoracic CT for staging bronchogenic carcinoma: Does IV contrast enhancement change stage and management. Scientific Programat the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 1998. e-Pub 1998.
73. Erasmus JJ, Patz EF, McAdams HP. FDG-PET imaging of adrenal masses in patients with lung cancer. Scientific Program at the 14th Annual Meeting and Postgraduate Course of the Society of Thoracic Radiology, 1996.
74. Dhillon GS, Erasmus JJ, Sauerbrei EE. Long term follow-up of infants with intraparenchymal hemorrhages on brain ultrasound. Canadian Association of Radiologists Annual Scientific Meeting, 1992.

Book Chapters

1. Carter BW, Erasmus JJ. Current concepts in the diagnosis and staging of lung cancer. In: Diseases of the Chest, Breast, Heart and Vessels 2019-2022: Diagnostic and Interventional Imaging. Springer, 2019.
2. Rice TW, Kelsen D, Blackstone EH, Ishwaran H, Patil DT, Bass AJ, Erasmus JJ, Gerdes H, Hofstetter WL. Esophagus and esopagogastric junction. In: AJCC Cancer Staging Manual. 8th. Springer: Chicago, IL, 185-202, 2017.
3. Ajani JA, In H, Sano T, Gaspar LE, Erasmus JJ, Tang LH, Washington MK, Gerdes H, Wittekind CW, Mansfield PF, Rimmer C, Hofstetter WL, Kelsen D. Stomach. In: AJCC Cancer Staging Manual. 8th. Springer: Chicago, IL, 203-220, 2017.
4. Erasmus JJ, Rossi SE. Neoplastic disease of the lung. In: CT and MRI of the Whole Body. 6th. Elsevier: Philadelphia, PA, 984-1021, 2017.
5. Erasmus JJ, Kong F, Macapinlac HA. Positron emission tomography imaging of lung cancer. In: Thoracic Oncology. 2nd. IASLC Press: Aurora, Colorado, 219-232, 2017.
6. Christensen JD, Erasmus JJ, Patz EF. Catheter drainage of intrathoracic collections. In: Handbook of Interventional Radiological Procedures. 5th. Wolters Kluwer: Philadelphia, 446-452, 2016.
7. Berkowitz Y, Erasmus, J. Limitations of noninvasive staging in lung cancer. In: Diagnosis and Staging of Lung Cancer: A Minimally Invasive Approach. People’s Medical Publishing House-USA: Shelton, CT, 2015.
8. Betancourt Cuellar SL, Marom EM, Erasmus JJ. Imaging lung cancer. In: Lung Cancer. John Wiley & Sons, Inc: Philadelphia, PA, 2015.
9. Erasmus JJ, Kong F, Macapinlac HA. PET imaging of lung cancer. In: Thoracic Oncology: The IASLC Multidisciplinary Approach. IASLC Press: Aurora, Colorado, 315-331, 2014.
10. Erasmus JJ, Marom EM, Huynh TT, and Patz EF. Radiological imaging of thoracic abnormalities. In: Surgery of the Chest. 9th. Elsevier, Inc: Philadelphia, PA, 26-38, 2014.
11. Steiner RM, Erasmus JJ. Editors, Special monograph issue: RadioGraphics. In: Cardiothoracic Imaging: Current Practice and Recent Innovations. 6th, 1465-1768, 2014.
12. Erasmus JJ, Stewart DJ, Komaki R, Swisher SG. Lung cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier, Inc: Philadelphia, PA, 35-61, 2012.
13. Benveniste MF, Herzog CE, Zage PE, Erasmus JJ. Primary mediastinal neoplasms. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier, Inc: Philadelphia, PA, 63-78, 2012.
14. Patz EF, Erasmus JJ. Management of malignant and parapneumonic pleural effusions and lung abscess with percutaneous drainage. In: Handbook of Interventional Radiologic Procedures. Lippincott Williams and Wilkins, 486-494, 2011.
15. Erasmus JJ. Staging, restaging and response evaluation of non-small cell lung cancer. In: Diseases of the Heart, Chest and Breast: Diagnostic Imaging and Interventional Techniques. Springer-Verlag. Inc: Milan, Italy, 203-210, 2011.
16. Vilar J, Erasmus JJ. Current concepts in diagnosis and staging of lung cancer. In: Diseases of the Heart, Chest and Breast: Diagnostic Imaging and Interventional Techniques. Springer-Verlag, Inc: Milan, Italy, 3-12, 2011.
17. Gutierrez J, Marom EM, Erasmus JJ, Patz EF.. Radiological imaging of thoracic abnormalities. In: Surgery of the Chest. 8th. Sabiston and Spencer, 25-37, 2009.
18. Erasmus JJ, Bucci MK, Munden RF. Radiation-induced lung disease. In: Imaging of the Chest. Elsevier, Inc: Philadelphia, 1225-1240, 2008.
19. Marom EM, Erasmus JJ, Patz EF. Pleural disease: Interventional radiology. In: Textbook of Pleural Diseases. Arnold Publishing: London, 259-270, 2008.
20. Erasmus JJ, McAdams HP, Rossi SE. Primary pulmonary neoplasms. In: CT and MR Imaging of the Whole Body. 5th. Mosby, Inc: St. Louis, 929-967, 2008.
21. Martinez S, McAdams HP, Spritzer CE, Erasmus JJ. The mediastinum. In: CT and MR Imaging of the Whole Body. 5th. Mosby, Inc: St. Louis, 969-1036, 2008.
22. Erasmus JJ. Hematogenously disseminated lung metastases. In: Chest Disease Sixth Series. American College of Radiology Syllabus, 11-20, 2008.
23. Erasmus JJ. Malignant pleural mesothelioma. In: Chest Disease Sixth Series. American College of Radiology Syllabus, 63-74, 2008.
24. Erasmus JJ. Primary chondrosarcoma of the chest wall. In: Chest Disease Sixth Series. American College of Radiology Syllabus, 97-105, 2008.
25. Erasmus JJ, Leung AN. Current concepts in the diagnosis and staging of lung cancer. In: Diseases of the Heart, Chest and Breast: Diagnostic Imaging and Interventional Techniques. Springer-Verlag, Inc: Milan, Italy, 3-10, 2007.
26. Sabloff BS, McAdams HP, Erasmus JJ. Non-invasive assessment of the solitary pulmonary nodule. In: New Techniques in Thoracic Imaging. Marcel Dekker, Inc: New York, 127-143, 2007.
27. Erasmus JJ, Truong MT, McAdams HP. Cancer diagnosis. In: Cancer Medicine Review. 7th. BC Decker, Inc: Ontario, Canada, 2006.
28. Erasmus JJ, Truong MT, McAdams HP. Neoplasms of the thorax. In: Cancer Medicine. BC Decker, Inc: Canada, 468-473, 2006.
29. Erasmus JJ, Truong MT, Mawlawi O. CT-PET of the thorax: Technique and pitfalls. In: Cardiopulmonary Imaging. American Roentgen Ray Society, 287-317, 2005.
30. Gutierrez J, Marom EM, Erasmus JJ, Patz EF. Imaging the thorax. In: Surgery of the Chest. 7th. Elsevier, Inc: Philadelphia, 19-32, 2005.
31. Erasmus JJ, McAdams HP, Rossi SE. Primary pulmonary neoplasms. In: CT and MR Imaging of the Whole Body. 4th. Mosby Publishing, Inc: St. Louis, 904-936, 2003.
32. Erasmus JJ, McAdams HP. Imaging neoplasms of the thorax. In: Cancer Medicine. BC Decker, Inc: Ontario, Canada, 517-521, 2003.
33. Erasmus JJ, McAdams HP. Cancer diagnosis. In: Cancer Medicine Review. 6th. BC Decker, Inc: Ontario, 32-42, 2003.
34. Erasmus JJ, McAdams HP, Munden RF. Staging of non-small cell lung cancer. In: Oncologic Imaging. American Roentgen Ray Society, 107-118, 2003.
35. Marom EM, Erasmus JJ, Patz EF. Interventional radiology for pleura diseases. In: Textbook of Pleural Diseases. Arnold Publishing: London, 238-248, 2003.
36. McAdams HP, Erasmus JJ, Tarver RD, Spritzer CE. The mediastinum. In: CT and MR Imaging of the Whole Body. 4th. Mosby, Inc: St. Louis, 937-996, 2003.
37. Patz EF, Erasmus JJ. Catheter drainage of intrathoracic fluid collections. In: Handbook of Interventional Radiologic Procedures. Lippincott Williams and Wilkins, 154-162, 2003.
38. Ginsberg MS, Erasmus JJ, Patz EF, Herman SJ. Imaging of the lung. In: Thoracic Surgery. Churchill Livingstone: New York, 443-498, 2002.
39. Munden RF, Erasmus JJ. Thoracic imaging techniques for non-small cell and small cell lung cancer. In: Lung Cancer. Springer-Verlag: New York, 35-56, 2002.
40. Erasmus JJ, McAdams HP, Crotty E. Non-invasive assessment of the solitary pulmonary nodule. In: New Techniques in Thoracic Imaging. Marcel Dekker, Inc: New York, 25-50, 2001.
41. Erasmus JJ, Patz EF, Goodman PC. Primary pulmonary neoplasms. In: Radiology: Diagnosis, Imaging, Intervention, 1999.
42. Erasmus JJ, Gilkeson RC, Goodman PC. Chest imaging. In: Duke Radiology Case Review. Lippincott-Raven Publishers: Philadelphia, 1-57, 1997.
43. Erasmus JJ, Patz EF. Diagnostic imaging of bronchogenic carcinoma. In: Pulmonary and Cardiac Imaging. Marcel Dekker, Inc: New York, 69-103, 1997.
44. Benveniste M, Gomez D, Sabloff BS, Erasmus JJ. Radiation induced lung disease. In: Muller’s Imaging of the Chest. 2nd. Elsevier.

Books (edited and written)

1. Erasmus JJ. Oncologic imaging: A multidisciplinary approach. Ed(s) Silverman PM. Elsevier, Inc: Philadelphia, PA, 35-93, 2012.

Letters to the Editor

1. Branstetter BF 4th, Meltzer CC, Truong MT, Erasmus JJ. PET/CT of teflon granulomas. Am J Roentgenol 183: 1173-1174, 2004.